Publications

09 Aug 2017
News

Non-Executive Directors Need To Align With Managers -- Without Losing Their Independence

06 Jun 2023
Cold Call Podcast

The Opioid Crisis, CEO Pay, and Shareholder Activism

Keywords: Re: Suraj Srinivasan; Health; Health; Health

On Competition, Updated and Expanded Edition

For the past two decades, Michael Porter's work has towered over the field of competitive strategy. On Competition, Updated and Expanded Edition brings together more than a dozen of Porter's landmark articles from the Harvard Business Review. Five are new... View Details

January 2017
Supplement

Intrapreneurship at DaVita HealthCare Partners: Cash Flow Tool

By: Joseph B. Fuller and Christopher Payton

DaVita Healthcare Partners Inc. (DaVita) is one of the U.S.'s leading dialysis providers, a process whereby persons with end-stage renal disease (ESRD) are connected to a machine that performs the functions of a healthy kidney. Kent Thiry, DaVita's CEO, has expanded... View Details

Keywords: Intrapreneurship; Entrepreneurial Organizations; Startup Management; Startup; Strategic Positioning; Corporate Entrepreneurship; Corporate Strategy; Business Startups; Strategic Planning; Competitive Strategy; Health Industry; United States

Program

General Management Program

organization, the program delivers the tools you need to capitalize on technological disruption and digital transformation and play a more strategic role in corporate success. This includes: Read More Considering global and industry... View Details

18 Oct 2021
Blog Post

Embracing Activism for Social Change

In 2020, the city of Detroit logged some 7,000 calls involving mental health emergencies—a critical issue, notes Detroit Mayor Mike Duggan, who says, “When the mentally ill turn to the police for a response, the system is broken.” To fix... View Details

Web

Publications - Faculty & Research

Keywords: Diagnostics ; Organization Design ; Change Management ; Disruption ; Transformation ; Health Care and Treatment ; AI and Machine Learning ; Technological Innovation ; Technology Adoption ; Disruptive Innovation ; Management... View Details

January 2003 (Revised May 2003)
Case

Heineken NV: Workplace HIV/AIDS Programs in Africa (C)

Third in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs (antiretroviral therapy) to... View Details

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa

March 2010
Supplement

Whose Money Is It Anyway? (C)

By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon

The case describes how the Brigham and Women's Physicians Organization and its corporate parent resolved the issue of how the disputed funds would be distributed and used. View Details

Keywords: Corporate Governance; Business Subsidiaries; Organizational Design; Conflict and Resolution; Resource Allocation; Health Industry

27 Sep 2011
First Look

First Look: September 27

learning and governance process. Implications for organization and leadership development and corporate governance are discussed. Read the paper: http://www.emeraldinsight.com/books.htm?chapterid=1937908&show=pdf Markets as Networks:... View Details

Keywords: Sean Silverthorne

Kym Lew Nelson

Kym Lew Nelson joined the NOM unit of the Harvard Business School as a Visiting Lecturer in January of 2020. In July of 2020, she became a Senior Lecturer in the Negotiations unit. Prior to joining the faculty, Kym was a guest lecturer in the Negotiations class at... View Details

October 2021 (Revised October 2022)
Case

The Opioid Settlement and Controversy Over CEO Pay at AmerisourceBergen

By: Suraj Srinivasan and Li-Kuan Ni

In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged had contributed to the nationwide... View Details

January 2020
Background Note

Climate Change in 2020: Implications for Business

By: Rebecca M. Henderson, Sophus A. Reinert and Mariana Oseguera

This note provides general information about climate change and its implications for business. Included is an overview of climate change science and a number of its impacts, including rising sea levels, changing weather patterns and extreme weather, pressure on water... View Details

January 2023
Case

Natura: Weathering the Pandemic at Brazil's Cosmetic Giant

By: Brian Trelstad, Pedro Levindo and Carla Larangeira

Brazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts... View Details

November 2020
Supplement

Valuing Celgene's CVR

By: Benjamin C. Esty and Daniel Fisher

When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details

Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States